Dr. Hari Kotturi
ProfessorClemson University, USA
Highest Degree
Ph.D. in Microbiology from Clemson University, USA
Share this Profile
Area of Interest:
Selected Publications
- Heidari, F., M. Razavi, M.E. Bahrololoom, M. Yazdimamaghani, M. Tahriri, H. Kotturi and L. Tayebi, 2018. Evaluation of the mechanical properties, in vitro biodegradability and cytocompatibility of natural chitosan/hydroxyapatite/nano-Fe3O4 composite. Ceram. Int., 44: 275-281.
CrossRef | Direct Link | - Abuabed, A., H. Zafar, E. Sawyer, B. Pallipparambil, H. Jamadagni and M. Khandaker, 2017. Evaluation of polyethylene glycol diacrylate-polycaprolactone scaffolds for tissue engineering applications. J. Funct. Biomater, Vol. 8. 10.3390/jfb8030039.
CrossRef | Direct Link | - Kotturi, H., G. Waris, A. Mohammed, P. Chandrakesan, R. May and N. Ali, 2016. (Z)-3,5,4'-trimethoxystilbene limits hepatitis c and cancer pathophysiology by blocking microtubule dynamics and cell-cycle progression. Cancer Res., 76: 4887-4896.
- Heidari, F., M. Razavi, M.E. Bahrololoom, R. Bazargan-Lari, D. Vashaee, H. Kotturi and L. Tayebi, 2016. Mechanical properties of natural chitosan/hydroxyapatite/magnetite nanocomposites for tissue engineering applications. Mater. Sci. Eng., 65: 338-344.
CrossRef | Direct Link | - Yazdimamaghani, M., M. Razavi, M. Mozafari, D. Vashaee, H. Kotturi and L. Tayebi, 2015. Biomineralization and biocompatibility studies of bone conductive scaffolds containing poly (3, 4-ethylenedioxythiophene): Poly (4-styrene sulfonate) (PEDOT: PSS). J. Mater. Sci.: Mater. Med., Vol. 26. 10.1007/s10856-015-5599-8.
CrossRef | - Rad, T.A., N. Ali, H.S.R. Kotturi, M. Yazdimamaghani, J. Smay, D. Vashaee and L. Tayebi, 2014. Conducting scaffolds for liver tissue engineering. J. Biomed. Mater. Res. Part A, 102: 4169-4181.
CrossRef | Direct Link | - Wei, Y., J. Li and H. Kotturi, 2011. Cancer Gene Therapy Via NKG2D and FAS Pathways. In: Targets in gene therapy, You, Y.,( Ed.). InTech Publisher, Croatia, pp:244-248.
- Kotturi, H.S.R., J. Li, M. Branham-O'Connor, X. Yu, T.E. Wagner and Y. Wei, 2010. In vitro and in vivo delivery of novel anticancer fusion protein MULT1E/FasTI via adenoviral vectors. Cancer gene therapy, 17: 164-170.
Direct Link | - Branham-O'Connor, M., J. Li, H.S. Kotturi, X. Yu, T.E. Wagner and Y. Wei, 2010. Fusion induced reversal of dendritic cell maturation: An altered expression of inflammatory chemokine and chemokine receptors in dendritomas. Oncol. Rep., 23: 545-550.
CrossRef | Direct Link | - Kotturi, H., J. Li, M. Branham-O'Connor, S.L. Stickel, X. Yu, T.E. Wagner and Y. Wei, 2008. Tumor cells expressing a fusion protein of MULT1 and Fas are rejected in vivo by apoptosis and NK cell activation. Gene Ther., 15: 1302-1310.
CrossRef | Direct Link |